Endocrine immune interactions in human parturition

Molecular and Cellular Endocrinology

Volumn 335, Issue 1, 2011, Pages 52-59

  Golightly, E ^a   Jabbour, H N ^b   Norman, J E ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Endocrine; Immune; Inflammation; Parturition

Indexed keywords

CHEMOKINE; CORTICOTROPIN; CYCLOOXYGENASE 2; CYTOKINE; ESTROGEN; GELATINASE B; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; NEUTROPHIL COLLAGENASE; OXYTOCIN; OXYTOCIN RECEPTOR; PROGESTERONE; TUMOR NECROSIS FACTOR ALPHA;

BIRTH; CELL INVASION; DYSTOCIA; ENDOCRINE SYSTEM; ENZYME ACTIVITY; FETUS MEMBRANE; HUMAN; IMMUNE SYSTEM; INFLAMMATION; LABOR INDUCTION; MYOMETRIUM; PREMATURE LABOR; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; UPREGULATION; UTERINE CERVIX RIPENING;

CERVIX UTERI; CYTOKINES; EXTRAEMBRYONIC MEMBRANES; FEMALE; HORMONES; HUMANS; INFLAMMATION; MYOMETRIUM; PARTURITION; PREGNANCY; PREMATURE BIRTH;

EID: 79951579002     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2010.08.005     Document Type: Review

References (107)

1. Allport V.C., Pieber D., Slater D.M., Newton R., White J.O., Bennett P.R. Human labour is associated with nuclear factor-kappaB activity which mediates cyclo-oxygenase-2 expression and is involved with the 'functional progesterone withdrawal'. Mol. Hum. Reprod. 2001, 7(6):581-586.
2. Alvi S.A., Brown N.L., Bennett P.R., Elder M.G., Sullivan M.H. Corticotrophin-releasing hormone and platelet-activating factor induce transcription of the type-2 cyclo-oxygenase gene in human fetal membranes. Mol. Hum. Reprod. 1999, 5(5):476-480.
3. Belt A.R., Baldassare J.J., Molnar M., Romero R., Hertelendy F. The nuclear transcription factor NF-kappaB mediates interleukin-1beta-induced expression of cyclooxygenase-2 in human myometrial cells. Am. J. Obstet. Gynecol. 1999, 181(2):359-366.
4. Blanks A.M., Thornton S. The role of oxytocin in parturition. BJOG 2003, 110(Suppl. 20):46-51.
5. Blanks A.M., Vatish M., Allen M.J., Ladds G., de Wit N.C., Slater D.M., Thornton S. Paracrine oxytocin and estradiol demonstrate a spatial increase in human intrauterine tissues with labor. J. Clin. Endocrinol. Metab. 2003, 88(7):3392-3400.
6. Boroditsky R.S., Reyes F.I., Winter J.S., Faiman C. Maternal serum estrogen and progesterone concentrations preceding normal labor. Obstet. Gynecol. 1978, 51(6):686-691.
7. Campbell E.A., Linton E.A., Wolfe C.D., Scraggs P.R., Jones M.T., Lowry P.J. Plasma corticotropin-releasing hormone concentrations during pregnancy and parturition. J. Clin. Endocrinol. Metab. 1987, 64(5):1054-1059.
8. Challis J.R., Lockwood C.J., Myatt L., Norman J.E., Strauss J.F., Petraglia F. Inflammation and pregnancy. Reprod. Sci. 2009, 16(2):206-215.
9. Chapman N.R., Europe-Finner G.N., Robson S.C. Expression and deoxyribonucleic acid-binding activity of the nuclear factor kappaB family in the human myometrium during pregnancy and labor. J. Clin. Endocrinol. Metab. 2004, 89(11):5683-5693.
10. Condon J.C., Jeyasuria P., Faust J.M., Wilson J.W., Mendelson C.R. A decline in the levels of progesterone receptor coactivators in the pregnant uterus at term may antagonize progesterone receptor function and contribute to the initiation of parturition. Proc. Natl. Acad. Sci. U.S.A. 2003, 100(16):9518-9523.
11. Condon J.C., Hardy D.B., Kovaric K., Mendelson C.R. Up-regulation of the progesterone receptor (PR)-C isoform in laboring myometrium by activation of nuclear factor-kappaB may contribute to the onset of labor through inhibition of PR function. Mol. Endocrinol. 2006, 20(4):764-775.
12. da Fonseca E.B., Bittar R.E., Carvalho M.H., Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am. J. Obstet. Gynecol. 2003, 188(2):419-424.
13. Dodd J.M., Flenady V.J., Cincotta R., Crowther C.A. Progesterone for the prevention of preterm birth: a systematic review. Obstet. Gynecol. 2008, 112(1):127-134.
14. Dudley D.J. Immunoendocrinology of preterm labor: the link between corticotropin-releasing hormone and inflammation. Am. J. Obstet. Gynecol. 1999, 180(1 Pt 3):S251-S256.
15. El Khwad M., Stetzer B., Moore R.M., Kumar D., Mercer B., Arikat S., Redline R.W., Mansour J.M., Moore J.J. Term human fetal membranes have a weak zone overlying the lower uterine pole and cervix before onset of labor. Biol. Reprod. 2005, 72(3):720-726.
16. Elliott C.L., Slater D.M., Dennes W., Poston L., Bennett P.R. Interleukin 8 expression in human myometrium: changes in relation to labor onset and with gestational age. Am. J. Reprod. Immunol. 2000, 43(5):272-277.
17. Elliott C.L., Allport V.C., Loudon J.A., Wu G.D., Bennett P.R. Nuclear factor-kappa B is essential for up-regulation of interleukin-8 expression in human amnion and cervical epithelial cells. Mol. Hum. Reprod. 2001, 7(8):787-790.
18. Elovitz M.A., Wang Z., Chien E.K., Rychlik D.F., Phillippe M. A new model for inflammation-induced preterm birth: the role of platelet-activating factor and Toll-like receptor-4. Am. J. Pathol. 2003, 163(5):2103-2111.
19. Fidel P.L., Romero R., Wolf N., Cutright J., Ramirez M., Araneda H., Cotton D.B. Systemic and local cytokine profiles in endotoxin-induced preterm parturition in mice. Am. J. Obstet. Gynecol. 1994, 170(5 Pt 1):1467-1475.
20. Fonseca E.B., Celik E., Parra M., Singh M., Nicolaides K.H. Progesterone and the risk of preterm birth among women with a short cervix. N. Engl. J. Med. 2007, 357(5):462-469.
21. Friebe-Hoffmann U., Chiao J.P., Rauk P.N. Effect of IL-1beta and IL-6 on oxytocin secretion in human uterine smooth muscle cells. Am. J. Reprod. Immunol. 2001, 46(3):226-231.
22. Fuchs A.R., Fuchs F., Husslein P., Soloff M.S. Oxytocin receptors in the human uterus during pregnancy and parturition. Am. J. Obstet. Gynecol. 1984, 150(6):734-741.
23. Fuchs F., Stakemann G. Treatment of threatened premature labor with large doses of progesterone. Am. J. Obstet. Gynecol. 1960, 79:172-176.
24. Goldenberg R.L., Culhane J.F., Iams J.D., Romero R. Epidemiology and causes of preterm birth. Lancet 2008, 371(9606):75-84.
25. Gotkin J.L., Celver J., McNutt P., Shields A.D., Howard B.C., Paonessa D.J., Napolitano P.G. Progesterone reduces lipopolysaccharide-induced interleukin-6 secretion in fetoplacental chorionic arteries, fractionated cord blood, and maternal mononuclear cells. Am. J. Obstet. Gynecol. 2006, 195(4):1015-1019.
26. Grammatopoulos D., Milton N.G., Hillhouse E.W. The human myometrial CRH receptor: G proteins and second messengers. Mol. Cell Endocrinol. 1994, 99(2):245-250.
27. Grammatopoulos D., Thompson S., Hillhouse E.W. The human myometrium expresses multiple isoforms of the corticotropin-releasing hormone receptor. J. Clin. Endocrinol. Metab. 1995, 80(8):2388-2393.
28. Grammatopoulos D.K., Hillhouse E.W. Role of corticotropin-releasing hormone in onset of labour. Lancet 1999, 354(9189):1546-1549.
29. Grammatopoulos D.K., Hillhouse E.W. Activation of protein kinase C by oxytocin inhibits the biological activity of the human myometrial corticotropin-releasing hormone receptor at term. Endocrinology 1999, 140(2):585-594.
30. Hapangama D., Neilson J.P. Mifepristone for induction of labour. Cochrane Database Syst. Rev. 2009, 3:CD002865.
31. Hatthachote P., Gillespie J.I. Complex interactions between sex steroids and cytokines in the human pregnant myometrium: evidence for an autocrine signaling system at term. Endocrinology 1999, 140(6):2533-2540.
32. Hertelendy F., Romero R., Molnar M., Todd H., Baldassare J.J. Cytokine-initiated signal transduction in human myometrial cells. Am. J. Reprod. Immunol. 1993, 30(2-3):49-57.
33. Hertelendy F., Zakar T. Prostaglandins and the myometrium and cervix. Prostaglandins Leukot. Essent. Fatty Acids 2004, 70(2):207-222.
34. Irwin M., Hauger R.L., Jones L., Provencio M., Britton K.T. Sympathetic nervous system mediates central corticotropin-releasing factor induced suppression of natural killer cytotoxicity. J. Pharmacol. Exp. Ther. 1990, 255(1):101-107.
35. Ito A., Sato T., Ojima Y., Chen L.C., Nagase H., Mori Y. Calmodulin differentially modulates the interleukin 1-induced biosynthesis of tissue inhibitor of metalloproteinases and matrix metalloproteinases in human uterine cervical fibroblasts. J. Biol. Chem. 1991, 266(21):13598-13601.
36. Jain R., Zwickler D., Hollander C.S., Brand H., Saperstein A., Hutchinson B., Brown C., Audhya T. Corticotropin-releasing factor modulates the immune response to stress in the rat. Endocrinology 1991, 128(3):1329-1336.
37. Johnston T.A., Greer I.A., Kelly R.W., Calder A.A. Plasma prostaglandin metabolite concentrations in normal and dysfunctional labour. Br. J. Obstet. Gynaecol. 1993, 100(5):483-488.
38. Kalantaridou S.N., Makrigiannakis A., Zoumakis E., Chrousos G.P. Reproductive functions of corticotropin-releasing hormone. Research and potential clinical utility of antalarmins (CRH receptor type 1 antagonists). Am. J. Reprod. Immunol. 2004, 51(4):269-274.
39. Kamada M., Irahara M., Maegawa M., Ohmoto Y., Murata K., Yasui T., Yamano S., Aono T. Transient increase in the levels of T-helper 1 cytokines in postmenopausal women and the effects of hormone replacement therapy. Gynecol. Obstet. Invest. 2001, 52(2):82-88.
40. Kanda N., Tamaki K. Estrogen enhances immunoglobulin production by human PBMCs. J. Allergy Clin. Immunol. 1999, 103(2 Pt 1):282-288.
41. Keck C., Herchenbach D., Pfisterer J., Breckwoldt M. Effects of 17beta-estradiol and progesterone on interleukin-6 production and proliferation of human umbilical vein endothelial cells. Exp. Clin. Endocrinol. Diab. 1998, 106(4):334-339.
42. Kelly R.W. Inflammatory mediators and cervical ripening. J. Reprod. Immunol. 2002, 57(1-2):217-224.
43. Kikuchi N., Urabe M., Iwasa K., Okubo T., Tsuchiya H., Hosoda T., Tatsumi H., Honjo H. Atheroprotective effect of estriol and estrone sulfate on human vascular smooth muscle cells. J. Steroid Biochem. Mol. Biol. 2000, 72(1-2):71-78.
44. Kniss D.A., Rovin B., Fertel R.H., Zimmerman P.D. Blockade NF-kappaB activation prohibits TNF-alpha-induced cyclooxygenase-2 gene expression in ED27 trophoblast-like cells. Placenta 2001, 22(1):80-89.
45. Kumar D., Fung W., Moore R.M., Pandey V., Fox J., Stetzer B., Mansour J.M., Mercer B.M., Redline R.W., Moore J.J. Proinflammatory cytokines found in amniotic fluid induce collagen remodeling, apoptosis, and biophysical weakening of cultured human fetal membranes. Biol. Reprod. 2006, 74(1):29-34.
46. Laatikainen T.J., Raisanen I.J., Salminen K.R. Corticotropin-releasing hormone in amniotic fluid during gestation and labor and in relation to fetal lung maturation. Am. J. Obstet. Gynecol. 1988, 159(4):891-895.
47. Lappas M., Permezel M., Georgiou H.M., Rice G.E. Nuclear factor kappa B regulation of proinflammatory cytokines in human gestational tissues in vitro. Biol. Reprod. 2002, 67(2):668-673.
48. Ledingham M.A., Thomson A.J., Jordan F., Young A., Crawford M., Norman J.E. Cell adhesion molecule expression in the cervix and myometrium during pregnancy and parturition. Obstet. Gynecol. 2001, 97(2):235-242.
49. Linton E.A., Perkins A.V., Woods R.J., Eben F., Wolfe C.D., Behan D.P., Potter E., Vale W.W., Lowry P.J. Corticotropin releasing hormone-binding protein (CRH-BP): plasma levels decrease during the third trimester of normal human pregnancy. J. Clin. Endocrinol. Metab. 1993, 76(1):260-262.
50. March of Dimes March of Dimes White Paper on Preterm Birth 2009, The Global and Regional Toll, White Plains, New York.
51. Maret A., Coudert J.D., Garidou L., Foucras G., Gourdy P., Krust A., Dupont S., Chambon P., Druet P., Bayard F., Guery J.C. Estradiol enhances primary antigen-specific CD4 T cell responses and Th1 development in vivo. Essential role of estrogen receptor alpha expression in hematopoietic cells. Eur. J. Immunol. 2003, 33(2):512-521.
52. Martin J.A., Hamilton B.E., Sutton P.D., Ventura S.J., Menacker F., Kirmeyer S. Births: final data for 2004. Natl. Vital Stat. Rep. 2006, 55(1):1-101.
53. Mathur R.S., Landgrebe S., Williamson H.O. Progesterone, 17-hydroxyprogesterone, estradiol, and estriol in late pregnancy and labor. Am. J. Obstet. Gynecol. 1980, 136(1):25-27.
54. McLaren J., Malak T.M., Bell S.C. Structural characteristics of term human fetal membranes prior to labour: identification of an area of altered morphology overlying the cervix. Hum. Reprod. 1999, 14(1):237-241.
55. McLean M., Bisits A., Davies J., Woods R., Lowry P., Smith R. A placental clock controlling the length of human pregnancy. Nat. Med. 1995, 1(5):460-463.
56. Meis P.J., Klebanoff M., Thom E., Dombrowski M.P., Sibai B., Moawad A.H., Spong C.Y., Hauth J.C., Miodovnik M., Varner M.W., Leveno K.J., Caritis S.N., Iams J.D., Wapner R.J., Conway D., O'Sullivan M.J., Carpenter M., Mercer B., Ramin S.M., Thorp J.M., Peaceman A.M., Gabbe S. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N. Engl. J. Med. 2003, 348(24):2379-2385.
57. Merlino A.A., Welsh T.N., Tan H., Yi L.J., Cannon V., Mercer B.M., Mesiano S. Nuclear progesterone receptors in the human pregnancy myometrium: evidence that parturition involves functional progesterone withdrawal mediated by increased expression of progesterone receptor-A. J. Clin. Endocrinol. Metab. 2007, 92(5):1927-1933.
58. Mesiano S., Chan E.C., Fitter J.T., Kwek K., Yeo G., Smith R. Progesterone withdrawal and estrogen activation in human parturition are coordinated by progesterone receptor A expression in the myometrium. J. Clin. Endocrinol. Metab. 2002, 87(6):2924-2930.
59. Mitchell B.F., Wong S. Changes in 17 beta, 20 alpha-hydroxysteroid dehydrogenase activity supporting an increase in the estrogen/progesterone ratio of human fetal membranes at parturition. Am. J. Obstet. Gynecol. 1993, 168(5):1377-1385.
60. Mitchell B.F., Taggart M.J. Are animal models relevant to key aspects of human parturition?. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009, 297(3):R525-R545.
61. Molnar M., Romero R., Hertelendy F. Interleukin-1 and tumor necrosis factor stimulate arachidonic acid release and phospholipid metabolism in human myometrial cells. Am. J. Obstet. Gynecol. 1993, 169(4):825-829.
62. Nishimori K., Young L.J., Guo Q., Wang Z., Insel T.R., Matzuk M.M. Oxytocin is required for nursing but is not essential for parturition or reproductive behavior. Proc. Natl. Acad. Sci. U.S.A. 1996, 93(21):11699-11704.
63. Norman J.E., Morris C., Chalmers J. The effect of changing patterns of obstetric care in Scotland (1980-2004) on rates of preterm birth and its neonatal consequences: perinatal database study. PLoS Med. 2009, 6(9):e1000153.
64. Norman J.E., Mackenzie F., Owen P., Mactier H., Hanretty K., Cooper S., Calder A., Mires G., Danielian P., Sturgiss S., MacLennan G., Tydeman G., Thornton S., Martin B., Thornton J.C., Neilson J.P., Norrie J. Progesterone for the prevention of preterm birth in twin pregnancy (STOPPIT): a randomised, double blind, placebo controlled study and meta analysis. Lancet 2009, 373(9680):2035-2040.
65. Osman I., Young A., Ledingham M.A., Thomson A.J., Jordan F., Greer I.A., Norman J.E. Leukocyte density and pro-inflammatory cytokine expression in human fetal membranes, decidua, cervix and myometrium before and during labour at term. Mol. Hum. Reprod. 2003, 9(1):41-45.
66. Peltier M.R. Immunology of term and preterm labor. Reprod. Biol. Endocrinol. 2003, 1:122.
67. Pirianov G., Waddington S.N., Lindstrom T.M., Terzidou V., Mehmet H., Bennett P.R. The cyclopentenone 15-deoxy-delta 12,14-prostaglandin J(2) delays lipopolysaccharide-induced preterm delivery and reduces mortality in the newborn mouse. Endocrinology 2009, 150(2):699-706.
68. Polan M.L., Loukides J., Nelson P., Carding S., Diamond M., Walsh A., Bottomly K. Progesterone and estradiol modulate interleukin-1 beta messenger ribonucleic acid levels in cultured human peripheral monocytes. J. Clin. Endocrinol. Metab. 1989, 69(6):1200-1206.
69. Rauk P.N., Chiao J.P. Interleukin-1 stimulates human uterine prostaglandin production through induction of cyclooxygenase-2 expression. Am. J. Reprod. Immunol. 2000, 43(3):152-159.
70. Rauk P.N., Friebe-Hoffmann U. Interleukin-1 beta down-regulates the oxytocin receptor in cultured uterine smooth muscle cells. Am. J. Reprod. Immunol. 2000, 43(2):85-91.
71. Rauk P.N., Friebe-Hoffmann U., Winebrenner L.D., Chiao J.P. Interleukin-6 up-regulates the oxytocin receptor in cultured uterine smooth muscle cells. Am. J. Reprod. Immunol. 2001, 45(3):148-153.
72. Riley S.C., Leask R., Chard T., Wathen N.C., Calder A.A., Howe D.C. Secretion of matrix metalloproteinase-2, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases into the intrauterine compartments during early pregnancy. Mol. Hum. Reprod. 1999, 5(4):376-381.
73. Robinson B.G., Emanuel R.L., Frim D.M., Majzoub J.A. Glucocorticoid stimulates expression of corticotropin-releasing hormone gene in human placenta. Proc. Natl. Acad. Sci. U.S.A. 1988, 85(14):5244-5248.
74. Robinson B.G., Arbiser J.L., Emanuel R.L., Majzoub J.A. Species-specific placental corticotropin releasing hormone messenger RNA and peptide expression. Mol. Cell Endocrinol. 1989, 62(2):337-341.
75. Rodriguez E., Lopez R., Paez A., Masso F., Montano L.F. 17Beta-estradiol inhibits the adhesion of leukocytes in TNF-alpha stimulated human endothelial cells by blocking IL-8 and MCP-1 secretion, but not its transcription. Life Sci. 2002, 71(18):2181-2193.
76. Rodts-Palenik S., Wyatt-Ashmead J., Pang Y., Thigpen B., Cai Z., Rhodes P., Martin J.N., Granger J., Bennett W.A. Maternal infection-induced white matter injury is reduced by treatment with interleukin-10. Am. J. Obstet. Gynecol. 2004, 191(4):1387-1392.
77. Rogers A., Eastell R. The effect of 17beta-estradiol on production of cytokines in cultures of peripheral blood. Bone 2001, 29(1):30-34.
78. Romero R., Sibai B.M., Sanchez-Ramos L., Valenzuela G.J., Veille J.C., Tabor B., Perry K.G., Varner M., Goodwin T.M., Lane R., Smith J., Shangold G., Creasy G.W. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue. Am. J. Obstet. Gynecol. 2000, 182(5):1173-1183.
79. Salas M.A., Brown O.A., Perone M.J., Castro M.G., Goya R.G. Effect of the corticotrophin releasing hormone precursor on interleukin-6 release by human mononuclear cells. Clin. Immunol. Immunopathol. 1997, 85(1):35-39.
80. Sayeed I., Stein D.G. Progesterone as a neuroprotective factor in traumatic and ischemic brain injury. Prog. Brain Res. 2009, 175:219-237.
81. Schmid B., Wong S., Mitchell B.F. Transcriptional regulation of oxytocin receptor by interleukin-1beta and interleukin-6. Endocrinology 2001, 142(4):1380-1385.
82. Seaman W.E., Gindhart T.D. Effect of estrogen on natural killer cells. Arthritis Rheum. 1979, 22(11):1234-1240.
83. Sennstrom M.B., Ekman G., Westergren-Thorsson G., Malmstrom A., Bystrom B., Endresen U., Mlambo N., Norman M., Stabi B., Brauner A. Human cervical ripening, an inflammatory process mediated by cytokines. Mol. Hum. Reprod. 2000, 6(4):375-381.
84. Shynlova O., Tsui P., Dorogin A., Lye S.J. Monocyte chemoattractant protein-1 (CCL-2) integrates mechanical and endocrine signals that mediate term and preterm labor. J. Immunol. 2008, 181(2):1470-1479.
85. Simhan H.N., Caritis S.N. Prevention of preterm delivery. N. Engl. J. Med. 2007, 357(5):477-487.
86. Slater D.M., Dennes W.J., Campa J.S., Poston L., Bennett P.R. Expression of cyclo-oxygenase types-1 and -2 in human myometrium throughout pregnancy. Mol. Hum. Reprod. 1999, 5(9):880-884.
87. Smith R. Parturition. N. Engl. J. Med. 2007, 356(3):271-283.
88. Smith R., Smith J.I., Shen X., Engel P.J., Bowman M.E., McGrath S.A., Bisits A.M., McElduff P., Giles W.B., Smith D.W. Patterns of plasma corticotropin-releasing hormone, progesterone, estradiol, and estriol change and the onset of human labor. J. Clin. Endocrinol. Metab. 2009, 94(6):2066-2074.
89. Straub R.H. The complex role of estrogens in inflammation. Endocr. Rev. 2007, 28(5):521-574.
90. Terrone D.A., Rinehart B.K., Granger J.P., Barrilleaux P.S., Martin J.N., Bennett W.A. Interleukin-10 administration and bacterial endotoxin-induced preterm birth in a rat model. Obstet. Gynecol. 2001, 98(3):476-480.
91. Terzidou V., Lee Y., Lindstrom T., Johnson M., Thornton S., Bennett P.R. Regulation of the human oxytocin receptor by nuclear factor-kappaB and CCAAT/enhancer-binding protein-beta. J. Clin. Endocrinol. Metab. 2006, 91(6):2317-2326.
92. Thomas, J., Paranjothy, S., 2001. The National Sentinel Caesarean Section Audit Report. RCOG, London.
93. Thomson A.J., Telfer J.F., Young A., Campbell S., Stewart C.J., Cameron I.T., Greer I.A., Norman J.E. Leukocytes infiltrate the myometrium during human parturition: further evidence that labour is an inflammatory process. Hum. Reprod. 1999, 14(1):229-236.
94. Thornton S., Davison J.M., Baylis P.H. Plasma oxytocin during the first and second stages of spontaneous human labour. Acta Endocrinol. (Copenh). 1992, 126(5):425-429.
95. Tribe R.M., Moriarty P., Dalrymple A., Hassoni A.A., Poston L. Interleukin-1beta induces calcium transients and enhances basal and store operated calcium entry in human myometrial smooth muscle. Biol. Reprod. 2003, 68(5):1842-1849.
96. Tulchinsky D., Hobel C.J., Yeager E., Marshall J.R. Plasma estrone, estradiol, estriol, progesterone, and 17-hydroxyprogesterone in human pregnancy. I. Normal pregnancy. Am. J. Obstet. Gynecol. 1972, 112(8):1095-1100.
97. Turnbull A.C., Patten P.T., Flint A.P., Keirse M.J., Jeremy J.Y., Anderson A.B. Significant fall in progesterone and rise in oestradiol levels in human peripheral plasma before onset of labour. Lancet 1974, 1(7848):101-103.
98. Vadillo-Ortega F., Gonzalez-Avila G., Furth E.E., Lei H., Muschel R.J., Stetler-Stevenson W.G., Strauss J.F. 92-kd type IV collagenase (matrix metalloproteinase-9) activity in human amniochorion increases with labor. Am. J. Pathol. 1995, 146(1):148-156.
99. Wadhwa P.D., Porto M., Garite T.J., Chicz-DeMet A., Sandman C.A. Maternal corticotropin-releasing hormone levels in the early third trimester predict length of gestation in human pregnancy. Am. J. Obstet. Gynecol. 1998, 179(4):1079-1085.
100. Wadhwa P.D., Culhane J.F., Rauh V., Barve S.S. Stress and preterm birth: neuroendocrine, immune/inflammatory, and vascular mechanisms. Matern. Child Health J. 2001, 5(2):119-125.
101. Wang H., Hirsch E. Bacterially-induced preterm labor and regulation of prostaglandin-metabolizing enzyme expression in mice: the role of toll-like receptor 4. Biol. Reprod. 2003, 69(6):1957-1963.
102. Watari M., Watari H., DiSanto M.E., Chacko S., Shi G.P., Strauss J.F. Pro-inflammatory cytokines induce expression of matrix-metabolizing enzymes in human cervical smooth muscle cells. Am. J. Pathol. 1999, 154(6):1755-1762.
103. Winkler M., Fischer D.C., Ruck P., Horny H.P., Kemp B., Rath W. Cytokine concentrations and expression of adhesion molecules in the lower uterine segment during parturition at term: relation to cervical dilatation and duration of labor. Z. Geburtshilfe Neonatol. 1998, 202(4):172-175.
104. Young A., Thomson A.J., Ledingham M., Jordan F., Greer I.A., Norman J.E. Immunolocalization of proinflammatory cytokines in myometrium, cervix, and fetal membranes during human parturition at term. Biol. Reprod. 2002, 66(2):445-449.
105. Young W.S., Shepard E., Amico J., Hennighausen L., Wagner K.U., LaMarca M.E., McKinney C., Ginns E.I. Deficiency in mouse oxytocin prevents milk ejection, but not fertility or parturition. J. Neuroendocrinol. 1996, 8(11):847-853.
106. Youssef R.E., Ledingham M.A., Bollapragada S.S., O'Gorman N., Jordan F., Young A., Norman J.E. The role of toll-like receptors (TLR-2 and -4) and triggering receptor expressed on myeloid cells 1 (TREM-1) in human term and preterm labor. Reprod. Sci. 2009, 16(9):843-856.
107. Yuan M., Jordan F., McInnes I.B., Harnett M.M., Norman J.E. Leukocytes are primed in peripheral blood for activation during term and preterm labour. Mol. Hum. Reprod. 2009, 15(11):713-724.